Evidence map›Paper›PMID 31112213›Full record

ArticleEuropean heart journal2019

Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Thomas W Johnson, Lorenz Räber, Carlo di Mario, Christos Bourantas, Haibo Jia, Alessio Mattesini, Nieves Gonzalo, Jose M de la Torre Hernandez, Francesco Prati, Konstantinos Koskinas and 12 more

2 registry-linked trialsAbstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in European heart journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 142 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06520904 phase4recruitingstarted 2024, after this paper: background citation

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography in Patients With Premature Coronary Artery Disease: a Randomized Controlled Trial

Ran2024Enrolled396Registered outcomes6Posted comparisons0ConditionsCoronary Artery Disease, Optical Coherence TomographyArmsPCSK9 inhibitor, Statin
PMID 33755142PMID 37666281PMID 31504418PMID 33303068PMID 33714389PMID 33865792PMID 34511134PMID 35368058PMID 35431172PMID 26655874PMID 27846344PMID 30553686other papers from this trial
Open the trial in the graph
NCT06182683 narecruitingnot on this mapstarted 2023, after this paper: background citation

Concurrent OPTIcal Coherence Tomography and frActional Flow REserve-guided Therapeutic Intervention in Patients With Coronary Artery Disease (OPTICARE-CAD)

TypeinterventionalSponsorKorea University Guro HospitalRan2023 to 2029Enrolled700ConditionsCoronary Artery Disease, Image, Atheroscleroses, CoronaryArmsoptical coherence tomography and fractional flow reserve, Coronary angiography
3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Thomas W JohnsonDepartment of Cardiology, Bristol Heart Institute, University Hospitals Bristol NHSFT & University of Bristol, Bristol, UK.
Lorenz RäberDepartment of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
Carlo di MarioStructural Interventional Cardiology, Careggi University Hospital, Florence, Italy.
Christos BourantasDepartment of Cardiology, Barts Heart Centre, Barts Health NHS & Queen Mary University, London, UK.
Haibo JiaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
Alessio MattesiniDepartment of Cardiology, Barts Heart Centre, Barts Health NHS & Queen Mary University, London, UK.
Nieves GonzaloDepartment of Cardiology, Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain.
Jose M de la Torre HernandezDepartment of Cardiology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
Francesco PratiDepartment of Cardiology, San Giovanni Hospital, Rome, Italy & CLI Foundation Rome, Italy.
Konstantinos KoskinasDepartment of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
Michael JonerDeutsches Herzzentrum München, DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Technische Universität München, Munich, Germany.
Maria D RaduDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
David ErlingeDepartment of Cardiology, Lund University, Skane University Hospital, Lund, Sweden.
Evelyn RegarDepartment of Cardiovascular Surgery, Zürich University Hospital, Zürich, Switzerland.
Vijay KunadianInstitute of Cellular Medicine, Newcastle University and Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
Akiko MaeharaCardiovascular Research Foundation, Columbia University, New York, NY, USA.
Robert A ByrneDeutsches Herzzentrum München, DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Technische Universität München, Munich, Germany.
Davide CapodannoDivision of Cardiology, Cardio-Thoraco-Vascular and Transplant Department, CAST, Rodolico Hospital, AOU "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy.
Takashi AkasakaWakayama Medical University, Wakayama, Japan.
William WijnsThe Lambe Institute for Translational Medicine and Curam, National University of Ireland Galway, Saolta University Healthcare Group, Galway, Ireland.
Gary S MintzCardiovascular Research Foundation, Columbia University, New York, NY, USA.
Giulio GuagliumiCardiovascular Department, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Funding

British Heart Foundation CS/15/7/31679
6 · The paper itself

Abstract

This consensus document is the second of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on the clinical use of intracoronary imaging including intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near infrared spectroscopy (NIRS)-IVUS. Beyond guidance of stent selection and optimization of deployment, invasive imaging facilitates angiographic interpretation and may guide treatment in acute coronary syndrome. Intravascular imaging can provide additional important diagnostic information when confronted with angiographically ambiguous lesions and allows assessment of plaque morphology enabling identification of vulnerability characteristics. This second document focuses on useful imaging features to identify culprit and vulnerable coronary plaque, which offers the interventional cardiologist guidance on when to adopt an intracoronary imaging-guided approach to the treatment of coronary artery disease and provides an appraisal of intravascular imaging-derived metrics to define the haemodynamic significance of coronary lesions.

Indexed as

Acute Coronary SyndromeAdultAgedCase-Control StudiesClinical Trials as TopicConsensusCoronary AngiographyCoronary Artery DiseaseDecision MakingEuropean UnionFemaleHemodynamicsHumansMaleMiddle AgedPercutaneous Coronary InterventionAcute coronary syndromeIntravascular imagingIntravascular ultrasoundOptical coherence tomographyPercutaneous coronary intervention

Identifiers

PMID31112213

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.